Literature DB >> 18366395

IgG4-related sclerosing lymphoplasmacytic pancreatitis and cholangitis mimicking carcinoma of pancreas and Klatskin tumour.

Moon-Tong Cheung1, Irene Lai-Oi Lo.   

Abstract

BACKGROUND: Autoimmune sclerosing pancreatitis is a well-known disease entity for years, particularly recognizing the difficulty in distinguishing it from malignancy. Immunohistochemical study showed that immunoglobulin IgG4 staining was positive in plasma cells of some autoimmune pancreatitis or cholangitis. The term 'autoimmune sclerosing pancreatocholangitis' was used as it was believed that they belonged to a range of disease involving both pancreas and biliary tree. It may also be part of a systemic fibro-inflammatory disease. PATIENTS AND METHODS: All the patients suffering from immunoglobulin G4 (IgG4)-related pancreatitis and cholangitis from May 2003 to September 2006 in Queen Elizabeth Hospital, Hong Kong were retrospectively studied.
RESULTS: A total of five patients with clinical diagnosis of IgG4-related autoimmune pancreatitis or cholangitis were analysed. All presented with jaundice or abdominal pain, mimicking carcinoma. Two patients had major resection, two patients were diagnosed by intraoperative biopsy and one was based on serum IgG4 level.
CONCLUSION: With the growing awareness of this relatively recently characterized clinical entity and its similar presentation to pancreatic carcinoma or bile duct cholangiocarcinoma, it is important for autoimmune sclerosing pancreatocholangitis to be included in the differential diagnosis of pancreaticobiliary disease. The management strategy has shown to be modified--from major resection to intraoperative biopsy and to the assay of serum IgG4 level without the necessity of histology confirmation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18366395     DOI: 10.1111/j.1445-2197.2008.04430.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  6 in total

1.  Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma.

Authors:  Abdul M Oseini; Roongruedee Chaiteerakij; Abdirashid M Shire; Amaar Ghazale; Joseph Kaiya; Catherine D Moser; Ileana Aderca; Teresa A Mettler; Terry M Therneau; Lizhi Zhang; Naoki Takahashi; Suresh T Chari; Lewis R Roberts
Journal:  Hepatology       Date:  2011-08-08       Impact factor: 17.425

2.  IgG4-associated cholangitis with cholangiocarcinoma.

Authors:  Beate K Straub; Irene Esposito; Daniel Gotthardt; Boris Radeleff; Dalibor Antolovic; Christa Flechtenmacher; Peter Schirmacher
Journal:  Virchows Arch       Date:  2011-04-12       Impact factor: 4.064

3.  Immunoglobulin G4-mediated sclerosing cholangitis as a risk factor for cholangiocarcinoma: A case report.

Authors:  Karin E Koopman; Elisabeth Bloemena; Geert Kazemier; Michael Klemt-Kropp
Journal:  Mol Clin Oncol       Date:  2016-09-30

4.  Recognition of other organ involvement might assist in the differential diagnosis of IgG4-associated sclerosing cholangitis without apparent pancreatic involvement: report of two cases.

Authors:  Takeshi Nowatari; Akihiko Kobayashi; Kiyoshi Fukunaga; Tatsuya Oda; Ryoko Sasaki; Nobuhiro Ohkohchi
Journal:  Surg Today       Date:  2012-08-02       Impact factor: 2.549

5.  IgG4-associated cholecystitis: another clue in the diagnosis of autoimmune pancreatitis.

Authors:  Michael D Leise; Thomas C Smyrk; Naoki Takahashi; Seth R Sweetser; Santhi S Vege; Suresh T Chari
Journal:  Dig Dis Sci       Date:  2010-11-17       Impact factor: 3.199

6.  Isolated IgG4-related sclerosing cholangitis misdiagnosed as malignancy in an area with endemic cholangiocarcinoma: a case report.

Authors:  Narongsak Rungsakulkij; Pattana Sornmayura; Penampai Tannaphai
Journal:  BMC Surg       Date:  2017-02-15       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.